Slow-releasing coposition of estrogen medicine and its preparing process
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- XINJIANG NUZILINE BIO PHARMA CO LTD
- Publication Date
- 2004-09-08
- Estimated Expiration
- Not applicable · inactive patent
Abstract
Description
technical field
[0001] The present invention relates to a pharmaceutical composition containing conjugated estrogen and a preparation method thereof. After oral administration, the sustained release composition of conjugated estrogen drug releases medicine regularly and slowly to treat and prevent menopausal syndrome occurring during female physiological or artificial menopause , prevention and treatment of osteoporosis and coronary heart disease, prevention and treatment of male Alzheimer's disease. Background technique
[0002] Since 1930, it was suggested that estrogen be used for the prevention and treatment of menopausal syndrome, thus establishing the basis of estrogen replacement therapy. In the 1950s, the United States first started the commercial production of estrogen replacement therapy products. At present, it is believed that the lack of estrogen after menopause should be adjusted, supplemented and treated like other endocrine gland dy...